These are exposure studies associated with the disease and all of its children.
|Reference||Associated Study Title||Author's Summary||Study Factors||Stressor||Receptors||Country||Medium||Exposure Marker||Measurements||Outcome|
|1.||Fan H, et al. (2014).||C8 Health Project (C8HP)||Using 2005-2006 data from a large perfluorocarbon (PFC)-exposure population survey, we compared serum PFCs concentrations between Gilbert Syndrome (GS) and non GS clinical phenotypes, in a cross sectional design, adjusting for standard risk factors, including age, body mass index, smoking status, socioeconomic status and gender.||sex||Fluorocarbons | perfluorodecanoic acid | perfluorododecanoic acid | perfluorohexanesulfonic acid | perfluorohexanoic acid | perfluorononanoic acid | perfluorooctane sulfonic acid | perfluorooctanoic acid | perfluoroundecanoic acid||Controls for disease:Gilbert Disease | Subjects with disease:Gilbert Disease | Study subjects||United States||serum||Fluorocarbons | perfluorodecanoic acid | perfluorododecanoic acid | perfluorohexanesulfonic acid | perfluorohexanoic acid | perfluorononanoic acid | perfluorooctane sulfonic acid | perfluorooctanoic acid | perfluoroundecanoic acid||Details||Gilbert Disease|
|2.||Min JY, et al. (2012).||National Health and Nutrition Examination Survey (NHANES)||We found that increases in serum perfluorooctanoic acid concentration were associated with a significantly increased risk of high homocysteine levels and hypertension in US adults.||alcohol drinking | race | sex | socioeconomic status | tobacco||perfluorooctanoic acid||Study subjects||United States||serum||perfluorooctanoic acid||Details||Hyperhomocysteinemia | Hypertension|